Tissue engineering scaffolds for controlled protein and plasmid delivery

被引:0
|
作者
Shea, LD [1 ]
Whittlesey, KJ [1 ]
Segura, T [1 ]
Jang, J [1 ]
Yang, Y [1 ]
机构
[1] Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA
来源
SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW TECHNOLOGIES | 2002年
关键词
tissue engineering; gene therapy; drug delivery;
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Tissue engineering approaches employ polymer scaffolds to supports, promote, and direct tissue formation by progenitor cells, which are either present in the surrounding tissue or transplanted with the polymer. We hypothesize that scaffolds capable of delivering tissue-inductive factors, or genes encoding for these factors, at the correct time and location, and in the appropriate concentration could enhance the effectiveness of current regenerative approaches. Scaffolds have been developed that provide a controlled, sustained delivery of protein and non-viral DNA. Polymeric scaffolds capable of sustained drug release can be fabricated by the assembly of drug-loaded microspheres and subsequent fusion of the microspheres using a gas foaming process. This process has been developed to regulate the amount released and the release rates for protein, naked DNA, and DNA complexed with cationic lipid and polymers. Alternatively, we have developed a controlled DNA delivery system based on the tethering of DNA complexes to a biomaterial surfaces. Complexes can be immobilized at high densities and cells cultured on the substrates can internalize and express the DNA. These systems for the controlled delivery of proteins, or DNA-encoding for these proteins, are versatile and can be readily applied to the regeneration of various tissues.
引用
收藏
页码:474 / 474
页数:1
相关论文
共 50 条
  • [1] Matrices and scaffolds for protein delivery in tissue engineering
    Tessmar, Joerg K.
    Goepferich, Achim M.
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (4-5) : 274 - 291
  • [2] Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds
    D M Salvay
    M Zelivyanskaya
    L D Shea
    Gene Therapy, 2010, 17 : 1134 - 1141
  • [3] Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds
    Salvay, D. M.
    Zelivyanskaya, M.
    Shea, L. D.
    GENE THERAPY, 2010, 17 (09) : 1134 - 1141
  • [4] Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering
    Storrie, Hannah
    Mooney, David J.
    ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (04) : 500 - 514
  • [5] Protein and plasmid DNA delivery from tissue engineering matrices.
    Mooney, DJ
    Shea, LD
    Peters, MC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U527 - U527
  • [6] Matrices and scaffolds for drug delivery in tissue engineering
    Domb, Avi
    Mikos, Antonios G.
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (4-5) : 185 - 186
  • [7] Matrices and scaffolds for DNA delivery in tissue engineering
    De Laporte, Laura
    Shea, Lonnie D.
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (4-5) : 292 - 307
  • [8] Lentivirus delivery by adsorption to tissue engineering scaffolds
    Shin, Seungjin
    Salvay, David M.
    Shea, Lonnie D.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 93A (04) : 1252 - 1259
  • [9] Clinical translation of controlled protein delivery systems for tissue engineering
    Kara L. Spiller
    Gordana Vunjak-Novakovic
    Drug Delivery and Translational Research, 2015, 5 : 101 - 115
  • [10] Clinical translation of controlled protein delivery systems for tissue engineering
    Spiller, Kara L.
    Vunjak-Novakovic, Gordana
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2015, 5 (02) : 101 - 115